Literatur
Staudinger T, Stoiser B, Müllner M, Locker GJ, Laczika K, Knapp S et al (2000) Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 28:1322–1328
Adams HA, Baumann G, Cascorbi I, Ebener C, Emmel M, Geiger S et al (2005) Empfehlungen zur Diagnostik und Therapie der Schockformen der IAG Schock der DIVI. Teil 2: Hypovolämischer Schock. Intensivmed 42:96–109
Janssens U, Graf J (2004) Was ist „Schock“? Internist 45(3):258–266
Graf J, Janssens U (2005) The early bird catches the worm. Crit Care Med 33:2412–2414
Leone M, Vallet B, Teboul JL, Mateo J, Bastien O, Martin C (2004) Survey of the use of catecholamines by French physicians. Intensive Care Med 30:984–988
Kellum JA, Pinsky MR (2002) Use of vasopressor agents in critically ill patients. Curr Opin Crit Care 8:236–241
Holmes CL (2005) Vasoactive drugs in the intensive care unit. Curr Opin Crit Care 11:413–417
Beale RJ, Hollenberg SM, Vincent J-L, Parrillo JE (2004) Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med 32:S455–S465
Müllner M, Urbanek B, Havel C, Losert H, Waechter F, Gamper G (2004) Vasopressors for shock. The Cochrane Database of Systematic Reviews (3):DOI: 10.1002/14651858.CD003709.pub2
Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J et al (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873
Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J (2000) Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS). Clinical Trials Group. Lancet 356:2139–2143
Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330:1717–1722
Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A et al (1995) A trial of goal-oriented Hemodynamic therapy in critically ill patients. N Engl J Med 333(16):1025–1032
Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H et al (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34:344–353
Sprung CL, Sakr Y, Vincent JL, LeGall JR, Reinhart K, Ranieri VM et al (2006) An evaluation of systemic inflammatory response syndrome signs in Sepsis Occurrence in Acutely Ill Patients (SOAP) study. Intensive Care Med 32:421–427
Vincent JL, Sakr Y, Reinhart K, Sprung CL, Gerlach H, Ranieri VM (2005) Is albumin administration in acutely ill asociated with increased mortality? Results of the SOAP study. Crit Care 9:745–754
Sakr Y, Reinhart K, Vincent JL, Sprung CL, Moreno R, Ranieri VM et al (2006) Does Dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) study. Crit Care Med 34:589–597
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20(6):864–874
Meier-Hellmann A, Bredle DL, Specht M, Spies C, Hannemann L, Reinhart K (1997) The effects of low dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. Intensive Care Med 23:31–37
Ruokonen E, Takala J, Kari A, Saxen H, Mertsola J, Hansen EJ (1993) Regional blood flow and oxygen transport in septic shock [see comments]. Crit Care Med 21(9):1296–1303
Neviere R, Mathieu D, Chagnon JL, Lebleu N, Wattel F (1996) The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med 154(6 Pt 1):1684–1688
Silva E, De Backer D, Creteur J, Vincent J-L (1998) Effects of vasoactive drugs on gastric intramucosal pH. Crit Care Med 26(10):1749–1759
Marik PE, Mohedin M (1994) The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 272:1354–1357
van den Berghe G, de Zegher F, Lauwers P (1994) Dopamine suppresses pituitary function in infants and children. Crit Care Med 22:1747–1753
van den Berghe G, de Zegher F (1996) Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 24:1580–1590
Rochon PA, Gurwitz JH, Sykora K, Mamdani M, Streiner DL, Garfinkel S et al (2005) Reader’s guide to critical appraisal of cohort studies: 1. Role and design. BMJ 330:895–897
Benson K, Hartz AJ (2000) A comparison of observational studies and randomized, controlled trials. N Engl J Med 342(25):1878–1886
Black N (1996) Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996; 312:1215–1218
Grimes DA, Schulz KF (2002) Bias and causal association in observational research. Lancet 359:248–252
Jadad AR, Rennie D (1998) The Randomized Controlled Trial Gets a Middle- aged Checkup. JAMA 279(4):319–320
Altman DG, Doré CJ (1990) Randomisation and baseline comparisons in clinical trials. Lancet 335:149–153
Schulz KF, Chalmers I, Hayes JA, Altman DG (1995) Empirical Evidence of the Bias. JAMA 273(5):408–412
Mamdani M, Sykora K, Li P, Normand SLT, Streiner DL, Austin PC et al (2005) Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 330:960–962
Greenland S, Morgenstern H (2001) Confounding in health research. Annu Rev Public Health 22:189–212
Shah BR, Laupacis A, Hux JE, Austin PC (2005) Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review. J Clin Epidemiol 58:550–559
Normand SLT, Sykora K, Li P, Mamdani M, Rochon PA, Anderson GM (2005) Reader's guide to critical appraisal of cohort studies: 3. Analytic strategies to reduce confounding. BMJ 330:1021–1023
Bailey AR, Burchett KR (1997) Effect of low-dose dopamine on serum concentrations of prolactin in the critically ill. Br J Anaesth 78:97–99
Gunning K, Rowan K (1999) Outcome data and scoring systems. BMJ 319:241–244
Suter PM (2005) Some ICUs save more lifes than others: we need to know why! Intensive Care Med 31:1301–1302
Graf J (2003) Guidelines for critical care services and personnel–Innovations and improvements in patient care? Crit Care Med 31(11):2709–2710
Levy MM, Macias WL, Vincent JL, Russel JA, Silva E, Trzaskoma B et al (2005) Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med 33:2194–2201
Schulz KF, Grimes DA (2005) Multiplicity in randomised trials II: subgroup and interim analyses. Lancet 355:1657–1661
ISIS-2 (Second International Study of Infarct Survival) Collaboration Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, or both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2:349–360
Sackett DL (2000) Why randomized controlled trials failed but needn't: 1. Failure to gain “coal-face” commitment and to use the uncertainty principle. CMAJ 162(9):1311–1314
Sprung C, Eidelman LA (1997) Ethical issues of clinical trials for the pulmonary artery catheter. New Horiz 5:264–267
Freedman B (1987) Equipoise and the ethics of clinical research. N Engl J Med 317(3):141–145
Graf J, Janssens U (2004) Evidenz-basierte Intensivmedizin: Praxis, Nutzen und Bedeutung. Anaesthesist 53(3):253–262
Graf J (2004) The good, the bad and the ugly–Qualitätsmerkmale publizierter Studien. In: Kuhlen R, Rossaint R (eds) Evidenzbasierte Medizin in Anästhesie und Intensivmedizin. Springer, Heidelberg
Bracco D (2006) Pharmacological support of the failing circulation: practice, evaluation, evidence and future directions. Crit Care Med 34:890–892
Bellomo R, Uchino S (2003) Cardiovascular monitoring tools: use and misuse. Curr Opin Crit Care 9:225–229
Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340(6):409–417
Hebert PC, Cook DJ, Wells G, Marshall J (2002) The design of randomized clinical trials in critically ill patients. Chest 121(4):1290–1300
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368–1377
Gao F, Melody T, Daniels DF, Giles S, Fox S (2005) The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care 9:R764–R770
Berenholtz SM, Pronovost PJ, Lipsett PA, Hobson D, Earsing K, Farley JE et al (2004) Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 32:2014–2020
Pronovost PJ, Angus DC, Dorman T, Robinson KA, Dremsizov TT, Young TL (2002) Physician staffing patterns and clinical outcomes in critically ill patients: a systematic review. JAMA 288(17):2151–2162
Pronovost PJ, Jenckes MW, Dorman T, Garrett E, Breslow MJ, Rosenfeld BA et al (1999) Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery. JAMA 281(14):1310–1317
Graf J (2006) Qualitätsmanagement und Leitlinien in der Intensivmedizin. Med Klinik 101(Sondernummer 1):115–118
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Graf, J., Wulf, H. & Janssens, U. Daily SOAP. Intensivmed 44, 3–10 (2007). https://doi.org/10.1007/s00390-006-0743-9
Issue Date:
DOI: https://doi.org/10.1007/s00390-006-0743-9